Related Experiment Video

Updated: Aug 8, 2026

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

BCG specificity of an inhibitory seric factor from tuberculosis anergic patients that acts on non-adherent PPD

H Mejía-López1, L G Martínez-García, E Zenteno

  • 1Departamento de Microbiología-Parasitología, Facultad de Medicina UNAM, México, D. F., México.

Immunological Investigations
|April 1, 1997
PubMed

Insights

Tuberculosis anergic immune sera inhibited lymphocyte transformation in PPD+ patients. Adsorbing sera with BCG removed this inhibitory effect on tuberculosis immune response.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Tuberculosis Research

Background:

  • Tuberculosis (TB) is a significant global health challenge.
  • Understanding immune responses in TB patients is crucial for developing effective treatments.
  • Anergy, a state of immune unresponsiveness, is observed in some TB patients.

Purpose of the Study:

  • To investigate the effect of anergic immune sera from TB patients on cellular immune responses.
  • To determine if adsorption with BCG modifies the immunomodulatory properties of these sera.
  • To assess the impact on lymphocyte transformation in response to purified protein derivative (PPD).

Main Methods:

  • Coculture of adherent and non-adherent cells from PPD+ TB patients (TBP PPD+).
  • Treatment of cocultures with anergic immune sera adsorbed with BCG.
  • Quantification of immune response using the lymphocyte transformation (LT) test with PPD antigen.

Main Results:

  • Anergic immune sera significantly inhibited the PPD-induced LT response in cocultures containing non-adherent cells from TBP PPD+ patients.
  • Adsorption of the anergic sera with BCG completely abolished this inhibitory effect.
  • The inhibitory effect was dependent on the presence of non-adherent cells from TBP PPD+ patients.

Conclusions:

  • Anergic immune sera from TB patients possess inhibitory factors that suppress cellular immune responses.
  • BCG adsorption removes these inhibitory factors, suggesting a potential role for BCG components in modulating these sera.
  • These findings contribute to understanding immune evasion mechanisms in tuberculosis and may inform therapeutic strategies.

More Related Videos

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...